Michael Daskalakis

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 31

Top Venues

Cancers

Journal of clinical medicine

Biomolecules

Biomedicines

Inselspital Universitätsspital Bern

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Inselspital Universitätsspital Bern Feb 01 2018

Switzerland

Senior Attending :: Hematology and Central Hematology Laboratory

Deutsches Krebsforschungszentrum - Jan 31 2018

Germany

Postdoctoral fellow :: Epigenomics and Cancer Risk Factors

Inselspital Universitätsspital Bern

Switzerland

Attending physician :: Hematology and Central Hematology Laboratory

Universitätsklinikum Freiburg

Germany

Medical doctor :: Transfusion Medicine

Universitätsklinikum Freiburg

Germany

Medical Doctor :: Medicine I, Hematology and Oncology

Publications

Urban Novak, Jarl E Mooyaart, Michael Daskalakis, Christof Scheid, Ludovic Gabellier, Ibrahim Yakoub-Agha, Ron Ram, Edouard Forcade, Lucía López-Corral, Emma Nicholson, Eugenio Galli, Friedrich Stölzel, Wolfgang Andreas Bethge, Eva Maria Wagner-Drouet, Jorinde D Hoogenboom, Stephan Mielke, Caroline Arber, Federico Simonetta, Christian Chabanon, Jürgen H E Kuball, Annalisa Ruggeri, Florent Malard
Choice of commercially available CAR-T cell products for r/r DLBCL & PMBCL in Europe: a survey on behalf of the cellular therapy & immunobiology working party (CTIWP) of the EBMT. Bone marrow transplantation (2024)
Julian Mehl, Dilara Akhoundova, Vera Ulrike Bacher, Barbara Jeker, Gaëlle Rhyner Agocs, Axel Ruefer, Susanne Soltermann, Martin Soekler, Annette Winkler, Michael Daskalakis, Thomas Pabst
Daratumumab during Myeloma Induction Therapy Is Associated with Impaired Stem Cell Mobilization and Prolonged Post-Transplant Hematologic Recovery. Cancers 16 (10) (2024)
Danaë Martinez Flores, Dilara Akhoundova, Katja Seipel, Myriam Legros, Marie-Noelle Kronig, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Gemtuzumab Ozogamicin and Stem Cell Mobilization for Autologous Stem Cell Transplantation in Favorable Risk Acute Myeloid Leukemia. Biomedicines 12 (7) (2024)
Matthias Eggimann, Dilara Akhoundova, Henning Nilius, Michèle Hoffmann, Michael Hayoz, Yolanda Aebi, Carlo R Largiadèr, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Safety and Efficacy of High-Dose Chemotherapy with TreoMel 200 vs. TreoMel 140 in Acute Myeloid Leukemia Patients Undergoing Autologous Stem Cell Transplantation. Cancers 16 (10) (2024)
Julian Mehl, Dilara Akhoundova, Vera Ulrike Bacher, Barbara Jeker, Gaëlle Rhyner Agocs, Axel Ruefer, Susanne Soltermann, Martin Soekler, Annette Winkler, Michael Daskalakis, Thomas Pabst
Daratumumab during Myeloma Induction Therapy Is Associated with Impaired Stem Cell Mobilization and Prolonged Post-Transplant Hematologic Recovery. Cancers 16 (10) (2024)
Danaë Martinez Flores, Dilara Akhoundova, Katja Seipel, Myriam Legros, Marie-Noelle Kronig, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Gemtuzumab Ozogamicin and Stem Cell Mobilization for Autologous Stem Cell Transplantation in Favorable Risk Acute Myeloid Leukemia. Biomedicines 12 (7) (2024)
Matthias Eggimann, Dilara Akhoundova, Henning Nilius, Michèle Hoffmann, Michael Hayoz, Yolanda Aebi, Carlo R Largiadèr, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Safety and Efficacy of High-Dose Chemotherapy with TreoMel 200 vs. TreoMel 140 in Acute Myeloid Leukemia Patients Undergoing Autologous Stem Cell Transplantation. Cancers 16 (10) (2024)
Danaë Martinez Flores, Dilara Akhoundova, Katja Seipel, Myriam Legros, Marie-Noelle Kronig, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Gemtuzumab Ozogamicin and Stem Cell Mobilization for Autologous Stem Cell Transplantation in Favorable Risk Acute Myeloid Leukemia. Biomedicines 12 (7) (2024)
Valerie Wittibschlager, Vera Ulrike Bacher, Katja Seipel, Naomi A Porret, Gertrud Wiedemann, Claudia Haslebacher, Michèle Hoffmann, Michael Daskalakis, Dilara Akhoundova, Thomas Pabst
CAR T-Cell Persistence Correlates with Improved Outcome in Patients with B-Cell Lymphoma. International journal of molecular sciences 24 (6) (2023)
Valerie Wittibschlager, Vera Ulrike Bacher, Katja Seipel, Naomi A Porret, Gertrud Wiedemann, Claudia Haslebacher, Michèle Hoffmann, Michael Daskalakis, Dilara Akhoundova, Thomas Pabst
CAR T-Cell Persistence Correlates with Improved Outcome in Patients with B-Cell Lymphoma. International journal of molecular sciences 24 (6) (2023)
Katja Seipel, Mariesol Abbühl, Vera Ulrike Bacher, Henning Nilius, Michael Daskalakis, Thomas Pabst
Clinical Impact of Single Nucleotide Polymorphism in CD-19 on Treatment Outcome in FMC63-CAR-T Cell Therapy. Cancers 15 (11) (2023)
Jarmila Anna Zdanowicz, Sophie Schneider, Carla Martignoni, Salima Lamari, Alexander Fuchs, Michael Daskalakis, Daniel Surbek
A Retrospective before and after Assessment of Multidisciplinary Management for Postpartum Hemorrhage. Journal of clinical medicine 12 (23) (2023)
Valerie Wittibschlager, Vera Ulrike Bacher, Katja Seipel, Naomi A Porret, Gertrud Wiedemann, Claudia Haslebacher, Michèle Hoffmann, Michael Daskalakis, Dilara Akhoundova, Thomas Pabst
CAR T-Cell Persistence Correlates with Improved Outcome in Patients with B-Cell Lymphoma. International journal of molecular sciences 24 (6) (2023)
Tim Lakomy, Dilara Akhoundova, Henning Nilius, Marie-Noëlle Kronig, Urban Novak, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Early Use of Corticosteroids following CAR T-Cell Therapy Correlates with Reduced Risk of High-Grade CRS without Negative Impact on Neurotoxicity or Treatment Outcome. Biomolecules 13 (2) (2023)
Tim Lakomy, Dilara Akhoundova, Henning Nilius, Marie-Noëlle Kronig, Urban Novak, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Early Use of Corticosteroids following CAR T-Cell Therapy Correlates with Reduced Risk of High-Grade CRS without Negative Impact on Neurotoxicity or Treatment Outcome. Biomolecules 13 (2) (2023)
Alexander D Heini, Philipp Beck, Vera Ulrike Bacher, Katja Seipel, Thilo Zander, Michael Daskalakis, Thomas Pabst
BeEAM Conditioning including High-Dose Bendamustine before Autologous Stem Cell Transplantation Is Safe and Effective in Patients with Waldenstrom's Macroglobulinemia. Journal of clinical medicine 12 (6) (2023)
Ashish Goyal, Jens Bauer, Joschka Hey, Dimitris N Papageorgiou, Ekaterina Stepanova, Michael Daskalakis, Jonas Scheid, Marissa L Dubbelaar, Boris Klimovich, Dominic Schwarz, Melanie Märklin, Malte Roerden, Yu-Yu Lin, Tobias Ma, Oliver Mücke, Hans-Georg Rammensee, Michael Lübbert, Fabricio Loayza-Puch, Jeroen Krijgsveld, Juliane Sarah Walz, Christoph Plass
DNMT and HDAC inhibition induces immunogenic neoantigens from human endogenous retroviral element-derived transcripts. Nature communications 14 (1) (2023)
Alexander D Heini, Philipp Beck, Vera Ulrike Bacher, Katja Seipel, Thilo Zander, Michael Daskalakis, Thomas Pabst
BeEAM Conditioning including High-Dose Bendamustine before Autologous Stem Cell Transplantation Is Safe and Effective in Patients with Waldenstrom's Macroglobulinemia. Journal of clinical medicine 12 (6) (2023)
Selina Bühler, Dilara Akhoundova, Barbara Jeker, Myriam Legros, Katja Seipel, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Stem Cell Mobilization with Ixazomib and G-CSF in Patients with Multiple Myeloma. Cancers 15 (2) (2023)
Alexander D Heini, Philipp Beck, Vera Ulrike Bacher, Katja Seipel, Thilo Zander, Michael Daskalakis, Thomas Pabst
BeEAM Conditioning including High-Dose Bendamustine before Autologous Stem Cell Transplantation Is Safe and Effective in Patients with Waldenstrom's Macroglobulinemia. Journal of clinical medicine 12 (6) (2023)
Tim Lakomy, Dilara Akhoundova, Henning Nilius, Marie-Noëlle Kronig, Urban Novak, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Early Use of Corticosteroids following CAR T-Cell Therapy Correlates with Reduced Risk of High-Grade CRS without Negative Impact on Neurotoxicity or Treatment Outcome. Biomolecules 13 (2) (2023)
Tim Lakomy, Dilara Akhoundova, Henning Nilius, Marie-Noëlle Kronig, Urban Novak, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Early Use of Corticosteroids following CAR T-Cell Therapy Correlates with Reduced Risk of High-Grade CRS without Negative Impact on Neurotoxicity or Treatment Outcome. Biomolecules 13 (2) (2023)
Fabrizio Huwyler, Rebekka Kunz, Vera Ulrike Bacher, Michèle Hoffmann, Urban Novak, Michael Daskalakis, Yara Banz, Thomas Pabst
Evaluation of Bortezomib-BeEAM (2BeEAM) as Chemotherapy Regimen Prior to ASCT in Patients with Mantle Cell Lymphoma. Cancers 15 (7) (2023)
Cédric Gillich, Dilara Akhoundova, Michael Hayoz, Yolanda Aebi, Carlo R Largiadèr, Katja Seipel, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Efficacy and Safety of High-Dose Chemotherapy with Treosulfan and Melphalan in Multiple Myeloma. Cancers 15 (10) (2023)
Selina Bühler, Dilara Akhoundova, Barbara Jeker, Myriam Legros, Katja Seipel, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Stem Cell Mobilization with Ixazomib and G-CSF in Patients with Multiple Myeloma. Cancers 15 (2) (2023)
Christian Rausch, Vera Ulrike Bacher, Manuela Rabaglio, Corinne Vorburger, Anke Klingenberg, Yara Banz, Michael Daskalakis, Thomas Pabst
Combining BeEAM with Brentuximab Vedotin for High-Dose Therapy in CD30 Positive Lymphomas before Autologous Transplantation-A Phase I Study. Journal of clinical medicine 11 (18) (2022)
Alexander D Heini, Vera Ulrike Bacher, Naomi A Porret, Gertrud Wiedemann, Myriam Legros, Denise Stalder Zeerleder, Katja Seipel, Urban Novak, Michael Daskalakis, Thomas Pabst
Experiences with Glofitamab Administration following CAR T Therapy in Patients with Relapsed Mantle Cell Lymphoma. Cells 11 (17) (2022)
Tanja Stoffel, Vera Ulrike Bacher, Yara Banz, Michael Daskalakis, Urban Novak, Thomas Pabst
BeEAM High-Dose Chemotherapy with Polatuzumab (Pola-BeEAM) before ASCT in Patients with DLBCL-A Pilot Study. Journal of clinical medicine 11 (13) (2022)
Sarah Farag, Ulrike Bacher, Barbara Jeker, Myriam Legros, Gaelle Rhyner, Jean-Marc Lüthi, Julian Schardt, Thilo Zander, Michael Daskalakis, Behrouz Mansouri, Chantal Manz, Thomas Pabst
Adding bendamustine to melphalan before ASCT improves CR rate in myeloma vs. melphalan alone: A randomized phase-2 trial. Bone marrow transplantation 57 (6) (2022)
Michael Daskalakis, Anita Feller, Jasmine Noetzli, Nicolas Bonadies, Volker Arndt, Gabriela Maria Baerlocher, null The Nicer Working Group
Potential to Improve Therapy of Chronic Myeloid Leukemia (CML), Especially for Patients with Older Age: Incidence, Mortality, and Survival Rates of Patients with CML in Switzerland from 1995 to 2017. Cancers 13 (24) (2021)
Michael Daskalakis, David Brocks, Yi-Hua Sheng, Md Saiful Islam, Alzbeta Ressnerova, Yassen Assenov, Till Milde, Ina Oehme, Olaf Witt, Ashish Goyal, Alexander Kühn, Mark Hartmann, Dieter Weichenhan, Manfred Jung, Christoph Plass
Reactivation of endogenous retroviral elements via treatment with DNMT- and HDAC-inhibitors. Cell cycle (Georgetown, Tex.) 17 (7) (2018)

Michael Daskalakis.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Michael Daskalakis